Dr Reddy's Laboratories Limited today announced that it has completed the acquisition of select divisions of Wockhardt Limited's branded generics business in India and a few other international territories of
Dr Reddy's closes Wockhardt branded generics deal on modified terms
Under new terms, DRL to hold back Rs 300 crore and release it if the revenue from sale of the products forming part of the business undertaking during the 12 months post-closing exceeds Rs 480 cr
 "Dr Reddy's")
Premium
Under the new terms, an amount of Rs 1,483 crore would be paid on the date of closing.
First Published: Jun 10 2020 | 5:22 PM IST
Key stories on business-standard.com are available only to BS Premium subscribers.
Register to read more on Business-Standard.com
